Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SKIN ELEMENTS LIMITED Capital/Financing Update 2025

Dec 14, 2025

65803_rns_2025-12-14_96c1f730-83ec-4de1-9241-a542fe882fad.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

SKIN ELEMENTS LIMITED

Announcement Type

New announcement

Date of this announcement

Monday December 15, 2025

The +securities to be quoted are: Other

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

were subject to shareholder approval on 28 Nov 2025, which has now been received.

Total number of +securities to be quoted

ASX +security Number of +securities to
code Security description be quoted Issue date
SKN ORDINARY FULLY PAID 500,000,000 12/12/2025

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities

1 / 6

Appendix 2A - Application for quotation of securities

Part 1 - Entity and announcement details

==> picture [21 x 22] intentionally omitted <==

1.1 Name of entity

SKIN ELEMENTS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

ACN

Registration number

608047794

1.3 ASX issuer code

SKN

1.4 The announcement is

New announcement

1.5 Date of this announcement

15/12/2025

Appendix 2A - Application for quotation of securities

2 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

Other

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

2.2 The +class of +securities to be quoted is:

Additional +securities in a class that is already quoted on ASX ("existing class")

2.3c Have these +securities been offered under a +disclosure document or +PDS? No

2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B

were subject to shareholder approval on 28 Nov 2025, which has now been received.

2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)

Appendix 2A - Application for quotation of securities

3 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Additional +securities to be quoted in an existing class ASX +security code and description SKN : ORDINARY FULLY PAID Issue date 12/12/2025 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details Number of +securities to be quoted 500,000,000 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities in lieu of unpaid director fees to Peter Malone and partial salary accrual but unpaid to Leo Fung Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.002000 Any other information the entity wishes to provide about the +securities to be quoted The purpose(s) for which the entity is issuing the securities To pay for services rendered Please provide additional details issued in accordance with shareholder approval 28 Nov 2025 Resolution 3 and 4

Appendix 2A - Application for quotation of securities

4 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)


+securities subject of this application)
Total number of
ASX +security code and description +securities on issue
SKNOD : OPTION EXPIRING 31-MAY-2026 133,351,198
SKN : ORDINARY FULLY PAID 2,825,214,115

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

Total number of
ASX +security code and description +securities on issue
SKNAS : OPTION EXPIRING 31-OCT-2025 EX $0.05 28,000,000
SKNAU : PERFORMANCE SHARES CLASS A 100,000,000
SKNAV : PERFORMANCE SHARES CLASS B 62,000,000
SKNAX : OPTION EXPIRING 21-FEB-2028 EX $0.01 219,061,355

Appendix 2A - Application for quotation of securities

5 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 5 - Other Listing Rule requirements

5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? No

5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1? Yes

5.2a Date of meeting or proposed meeting to approve the issue under listing rule 7.1

28/11/2025

Appendix 2A - Application for quotation of securities

6 / 6